Baldini A, Fassi Fehri H, Cerantola Y, Bayle F, Ravier E, Belot P Y, Arnouil N, Colombel M, Badet L
Hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France.
CHU Vaudois, 46, rue du Bugnon, 1011 Lausanne, Suisse.
Prog Urol. 2018 May;28(6):351-358. doi: 10.1016/j.purol.2018.03.010. Epub 2018 Apr 27.
To estimate the feasibility and the impact of an ERAS program after radical cystectomy for bladder cancer.
This was a retrospective study comparing a historical pre ERAS group, including all the patients undergoing cystectomy for bladder cancer from January 2013 to December 2015 with a classic procedure, and an interventional ERAS group after introducing an enhanced recovery protocol before, during and after surgery, from February 2016. The principal outcome was the postoperative length of stay. Secondary outcomes mesures were impact on perioperative complication rate (Clavien classification≥3B), readmission rate, reanimation length of stay, ileus rate and adherence to the ERAS protocol.
There were no differences between the 2 groups as far as demographics characteristics are concerned. In total, 97 patients were included, 56 in the control group, and 41 in the ERAS group. The adherence to the protocol was about 65.8%. The ERAS group had statistically significantly shorter median length of stay (D19 versus D14; P: 0.021). The major complications rate (Clavien≥3B) were about 23.2% for the control group and 12.1% for the ERAS group (P: NS). The reinsertion of nasogastric tube were higher in the control group (39.3% vs 21.9%; P: NS) and the readmission rate was about 7.1% in the control group versus 14.6% in the ERAS group (P: NS).
In conclusion, introduction and application of an enhanced recovery protocol (ERAS) after cystectomy for bladder cancer allowed for better management of postoperative outcomes. It is clearly feasible in cystectomy, and improve significantly the median postoperative length of stay. Moreover, it may be effective in terms of faster return of bowel function and reduction of majors complications.
评估膀胱癌根治性膀胱切除术后实施加速康复外科(ERAS)方案的可行性及影响。
这是一项回顾性研究,将2013年1月至2015年12月期间接受经典术式膀胱癌膀胱切除术的历史对照前ERAS组,与2016年2月起在手术前、手术期间及手术后引入强化康复方案的干预性ERAS组进行比较。主要结局指标为术后住院时间。次要结局指标包括对围手术期并发症发生率(Clavien分级≥3B)、再入院率、复苏住院时间、肠梗阻发生率及对ERAS方案的依从性的影响。
就人口统计学特征而言,两组之间无差异。总共纳入97例患者,对照组56例,ERAS组41例。方案依从率约为65.8%。ERAS组的中位住院时间在统计学上显著缩短(19天对14天;P:0.021)。对照组的主要并发症发生率(Clavien≥3B)约为23.2%,ERAS组为12.1%(P:无统计学意义)。对照组鼻胃管重新插入率更高(39.3%对21.9%;P:无统计学意义),对照组的再入院率约为7.1%,ERAS组为14.6%(P:无统计学意义)。
总之,膀胱癌膀胱切除术后引入并应用强化康复方案(ERAS)有助于更好地管理术后结局。在膀胱切除术中显然是可行的,且显著缩短了术后中位住院时间。此外,在促进肠道功能更快恢复和减少主要并发症方面可能是有效的。
4级。